These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2172396)

  • 1. An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies.
    Marshall GS; Ricciardi RP; Rando RF; Puck J; Ge RW; Plotkin SA; Gönczöl E
    J Infect Dis; 1990 Nov; 162(5):1177-81. PubMed ID: 2172396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
    Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
    J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity.
    Gönczöl E; deTaisne C; Hirka G; Berencsi K; Lin WC; Paoletti E; Plotkin S
    Vaccine; 1991 Sep; 9(9):631-7. PubMed ID: 1659051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.
    Britt WJ; Vugler L; Butfiloski EJ; Stephens EB
    J Virol; 1990 Mar; 64(3):1079-85. PubMed ID: 2154594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.
    Spaete RR; Thayer RM; Probert WS; Masiarz FR; Chamberlain SH; Rasmussen L; Merigan TC; Pachl C
    Virology; 1988 Nov; 167(1):207-25. PubMed ID: 2460994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
    Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G
    J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step.
    Ye X; Su H; Wrapp D; Freed DC; Li F; Yuan Z; Tang A; Li L; Ku Z; Xiong W; Jaijyan D; Zhu H; Wang D; McLellan JS; Zhang N; Fu TM; An Z
    PLoS Pathog; 2020 Aug; 16(8):e1008736. PubMed ID: 32745149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).
    Britt WJ; Vugler L; Stephens EB
    J Virol; 1988 Sep; 62(9):3309-18. PubMed ID: 2841483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
    Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
    J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.
    Cranage MP; Kouzarides T; Bankier AT; Satchwell S; Weston K; Tomlinson P; Barrell B; Hart H; Bell SE; Minson AC
    EMBO J; 1986 Nov; 5(11):3057-63. PubMed ID: 3024973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells.
    Wells DE; Vugler LG; Britt WJ
    J Gen Virol; 1990 Apr; 71 ( Pt 4)():873-80. PubMed ID: 2157800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells.
    Marshall GS; Fenger DP; Stout GG; Knights ME; Hunt LA
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1549-57. PubMed ID: 8757998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection.
    Schleiss MR; Jensen NJ
    J Virol Methods; 2003 Mar; 108(1):59-65. PubMed ID: 12565154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
    Speckner A; Glykofrydes D; Ohlin M; Mach M
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.
    Shimamura M; Mach M; Britt WJ
    J Virol; 2006 May; 80(9):4591-600. PubMed ID: 16611919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a novel vaccine against human cytomegalovirus based on a chimeric Ad5F35 adenovirus vector expressing the immunodominant antigenic domain 1 epitope.
    Zhao P; Ma D; Yan S; Shao N; Zhang J; Bi Z; Dai J; Ji M; Ji C
    Intervirology; 2009; 52(1):35-42. PubMed ID: 19372702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.